Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation

Oncogene

Volumn 22, Issue 24, 2003, Pages 3712-3720

  Yang, Hsin Sheng ^a   Knies, Jennifer L ^a   Stark, Cristi ^a   Colburn, Nancy H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

AP 1; c Fos; c Jun; Pdcd4; Transformation

Indexed keywords

COMPLEMENTARY DNA; PROTEIN C FOS; PROTEIN DERIVATIVE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR FRA 1; TRANSCRIPTION FACTOR FRA 2; TRANSCRIPTION FACTOR JUNB; TRANSCRIPTION FACTOR JUND; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; PDCD4 PROTEIN, MOUSE; PROTEIN; PROTEIN C JUN; RNA BINDING PROTEIN; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; AP 1 GENE; ARTICLE; CELL LINE; CONCENTRATION RESPONSE; ENZYME ACTIVATION; FUSION GENE; GEL MOBILITY SHIFT ASSAY; GENE; GENE EXPRESSION; GENETIC TRANSFECTION; MOUSE; NONHUMAN; PDCD4 GENE; PHENOTYPE; PLASMID; PRIORITY JOURNAL; REPORTER GENE; SERUM RESPONSIVE ELEMENT; TRANSACTIVATION; TUMOR SUPPRESSOR GENE; VECTOR CONTROL; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CELL DIVISION; CELL TRANSFORMATION; DNA RESPONSIVE ELEMENT; DOWN REGULATION; DRUG ANTAGONISM; PHYSIOLOGY;

ANIMALIA;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; DOWN-REGULATION; MICE; PROTEINS; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; RESPONSE ELEMENTS; RNA-BINDING PROTEINS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR AP-1;

EID: 0038209450     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206433     Document Type: Article

References (42)

1. Angel P, Szabowski A and Schorpp-Kistner M. (2001). Oncogene, 20, 2413-2423.
2. Azzoni L, Zatsepina O, Abede B, Bennett IM, Kanakaraj P and Perussia B. (1998). J. Immunol., 161, 3493-3500.
3. Bernstein LR and Walker SE. (1999). Biochim. Biophys. Acta, 1489, 263-280.
4. Chauhan D, Auclair D, Robinson EK, Hideshima T, Li GL, Podar K, Gupta D, Richardson P, Schlossman RL, Krett N, Chen LB, Munshi NC and Anderson KC. (2002). Oncogene, 21, 1346-1358.
5. Chinenov Y and Kerppola TK. (2001). Oncogene, 20, 2438-2452.
6. Cmarik JL, Min H, Hegamyer G, Zhan S, Kulesz-Martin M, Yoshinaga H, Matsuhashi S and Colburn NH. (1999). Proc. Natl. Acad. Sci. USA, 96, 14037-14042.
7. Colburn NH. (1980). Carcinogen. Compr. Surv., 5, 33-56.
8. Colburn NH, Former BF, Nelson KA and Yuspa SH. (1979). Nature, 281, 589-591.
9. Colburn NH, Wendel EJ and Abruzzo G. (1981). Proc. Natl. Acad. Sci. USA, 78, 6912-6916.
10. Coussens LM, Fingleton B and Matrisian LM. (2002). Science, 295, 2387-2392.
11. Domann FE, Levy JP, Birrer MJ and Bowden GT. (1994). Cell Growth Differ., 5, 9-16.
12. Dong Z, Lavrovsky V and Colburn NH. (1995a). Carcinogenesis, 16, 749-756.
13. Dong Z, Watts RG, Sun Y, Zhan S-N and Colburn N. (1995b). Int. J. Oncol., 7, 359-364.
14. Holt JT, Gopal TV, Moulton AD and Nienhuis AW. (1986). Proc. Natl. Acad. Sci. USA, 83, 4794-4798.
15. Hsu TC, Nair R, Tulsian P, Camalier CE, Hegamyer GA, Young MR and Colburn NH. (2001). Cancer Res., 61, 4160-4168.
16. Hsu TC, Young MR, Cmarik J and Colburn NH. (2000). Free Radic. Biol. Med., 28, 1338-1348.
17. Kazumi S and Colburn NH. (2002). Oncogene, 21, 2181-2190.
18. Kovary K and Bravo R. (1991). Mol. Cell. Biol., 11, 4466-4472.
19. Li JJ, Cao Y, Young MR and Colburn NH. (2000). Mol. Carcinogen., 29, 159-169.
20. Li JJ, Rhim JS, Schlege R, Vousden KH and Colburn NH. (1998). Oncogene, 28, 2711-2721.
21. Liu Y, Ludes-Meyers J, Zhang Y, Munoz-Medellin D, Kim HT, Lu C, Ge G, Schiff R, Hilsenbeck SG, Osborne CK and Brown PH. (2002). Oncogene, 21, 7680-7689.
22. Nishikura K and Murray JM. (1987). Mol. Cell. Biol., 7, 639-649.
23. Onishi Y and Kizaki H. (1996). Biochem. Biophys. Res. Commun., 228, 7-13.
24. Ozanne BW, McGarry L, Spence HJ, Johnston I, Winnie J, Meagher L and Stapleton G. (2000). Eur. J. Cancer, 36, 1640-1648.
25. Pause A, Methot N, Svitkin Y, Merrick WC and Sonenberg N. (1994). EMBO J., 13, 1205-1215.
26. Rapp UR, Troppmair J, Beck T and Birrer MJ. (1994). Oncogene, 9, 3493-3498.
27. Rogers Jr GW, Komar AA and Merrick WC. (2002). Prog. Nucleic Acid Res. Mol. Biol., 72, 307-331.
28. Schreiber M, Kolbus A, Piu F, Szabowski A, Mohle-Steinlein U, Tian J, Karin M, Angel P and Wagner EF. (1999). Genes Dev., 13, 607-619.
29. Schutte J, Minna JD and Birrer MJ. (1989a). Proc. Natl. Acad. Sci. USA, 86, 2257-2261.
30. Schutte J, Viallet J, Nau M, Segal S, Fedorko J and Minna J. (1989b). Cell, 59, 987-997.
31. Shaulian E and Karin M. (2001). Oncogene, 20, 2390-2400.
32. Shaulian E and Karin M. (2002). Nat. Cell. Biol., 4, E131-E136.
33. Shibahara K, Asano M, Ishida Y, Aoki T, Koike T and Honjo T. (1995). Gene, 166, 297-301.
34. Smith LM, Wise SC, Hendricks DT, Sabichi AL, Bos T, Reddy P, Brown PH and Birrer MJ. (1999). Oncogene, 18, 6063-6070.
35. Suzuki T, Murakami M, Onai N, Fukuda E, Hashimoto Y, Sonobe MH, Kameda T, Ichinose M, Miki K and Iba H. (1994). J. Virol., 68, 3527-3535.
36. Svitkin YV, Pause A, Haghighat A, Pyronnet S, Witherell G, Belsham GJ and Sonenberg N. (2001). RNA, 7, 382-394.
37. Takahashi K, Heine UI, Junker JL, Colburn NH and Rice JM. (1986). Cancer Res., 46, 5923-5932.
38. Watts RG, Ben-Ari ET, Bernstein LR, Birrer MJ, Winterstein D, Wendel E and Colburn NH. (1995). Mol. Carcinogen., 13, 27-36.
39. Yang HS, Jansen AP, Komar AA, Zheng X, Merrick WC, Costes S, Lockett SJ, Sonenberg N and Colburn NH. (2003). Mol. Cell. Biol., 23, 26-37.
40. Yang HS, Jansen AP, Nair R, Shibahara K, Verma AK, Cmarik JL and Colburn NH. (2001). Oncogene, 20, 669-676.
41. Young MR, Nair R, Bucheimer N, Tulsian P, Brown N, Chapp C, Hsu TC and Colburn NH. (2002). Mol. Cell. Biol., 22, 587-598.
42. Zhang ZH and DuBois RN. (2001). Oncogene, 20, 4450-4456.